News Focus
News Focus
icon url

Ajax133

04/29/13 12:45 PM

#5370 RE: sts66 #5365

BIO With all due respect: Since anti inflammatory aspect wasn't
one of the end points in either Marine or Anchor trials, it can't
be claimed in marketing the drug, or be on the label. It's academic at this point.
icon url

homebuilder_watcher

04/30/13 10:52 AM

#5435 RE: sts66 #5365

sts, I am not denying any of the science regarding inflammation, just that it is not accepted in the medical community at this time or any time soon. If I were to ask my doctor to prescribe vascepa for me (I don't have high TG) for inflammation issues, he woudl probably look at me like I was asking him about the benefit of accupuncture for inflammation, which most docs don't recognize as medicine. Perhaps that will change over time for vascepa but I don't think it will happen in time for it to matter to us as investors in AMRN as it will be gone before that becomes accepted broadly. That is why I don't concern myself about all the stuff regarding inflammation benefits